You have 9 free searches left this month | for more free features.

Condition

Lymphoma, Non-Hodgkin (2)

Chronic Lymphocytic Leukemia (1)

Healthy (1)

Leukemia, Lymphocytic, Chronic, B-Cell (1)

Overall Status

Active, not recruiting (1)

Completed (1)

Recruiting (1)

Sign in for free

Phase

phase 1 (3)

Sponsor

Janssen Research & Development, LLC (3)

Collaborator

Intervention

jnj-64264681 (3)

jnj-67856633 (1)

placebo (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Industry (3)

Study Type

Interventional (3)

jnj-64264681

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell Trial in Worldwide (JNJ-64264681)

Recruiting

Lymphoma, Non-Hodgkin
Leukemia, Lymphocytic, Chronic, B-Cell

JNJ-64264681

New York, New York
+15 more

Jan 27, 2023

Lymphoma, Non-Hodgkin, Chronic Lymphocytic Leukemia Trial in Worldwide (JNJ-64264681, JNJ-67856633)

Active, not recruiting

Lymphoma, Non-Hodgkin
Chronic Lymphocytic Leukemia

JNJ-64264681
JNJ-67856633

Stony Brook, New York
+27 more

Aug 11, 2022

Healthy Trial in Merksem (JNJ-64264681, Placebo)

Completed

Healthy

JNJ-64264681
Placebo

Merksem, Belgium

Clinical Pharmacology Unit

Aug 20, 2019